Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuromuscular Diseases | 2 | 2022 | 63 | 1.410 |
Why?
|
| Diabetic Neuropathies | 6 | 2021 | 101 | 1.230 |
Why?
|
| Neural Conduction | 2 | 2020 | 112 | 0.770 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2020 | 4 | 0.760 |
Why?
|
| Patient Preference | 1 | 2022 | 218 | 0.710 |
Why?
|
| Neuralgia | 2 | 2021 | 251 | 0.620 |
Why?
|
| Myositis, Inclusion Body | 3 | 2023 | 8 | 0.620 |
Why?
|
| Placebo Effect | 1 | 2017 | 39 | 0.610 |
Why?
|
| Drinking | 1 | 2017 | 54 | 0.590 |
Why?
|
| Distal Myopathies | 1 | 2016 | 1 | 0.580 |
Why?
|
| Telemedicine | 1 | 2022 | 471 | 0.550 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2017 | 84 | 0.540 |
Why?
|
| Deglutition | 1 | 2017 | 171 | 0.530 |
Why?
|
| Genetic Testing | 1 | 2022 | 1589 | 0.480 |
Why?
|
| Receptors, Virus | 1 | 2014 | 157 | 0.470 |
Why?
|
| Retinitis Pigmentosa | 1 | 2014 | 79 | 0.460 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 244 | 0.440 |
Why?
|
| Ataxia | 1 | 2014 | 176 | 0.440 |
Why?
|
| Quinidine | 1 | 2012 | 16 | 0.430 |
Why?
|
| Dextromethorphan | 1 | 2012 | 13 | 0.430 |
Why?
|
| Acetamides | 2 | 2009 | 113 | 0.390 |
Why?
|
| Fatigue | 1 | 2017 | 1239 | 0.380 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2009 | 26 | 0.350 |
Why?
|
| Ribonucleotide Reductases | 1 | 2009 | 51 | 0.350 |
Why?
|
| DNA Mutational Analysis | 4 | 2014 | 2283 | 0.340 |
Why?
|
| Gastrointestinal Motility | 1 | 2009 | 92 | 0.340 |
Why?
|
| Thymectomy | 2 | 2020 | 79 | 0.320 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2009 | 126 | 0.310 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 311 | 0.310 |
Why?
|
| Myasthenia Gravis | 2 | 2020 | 99 | 0.300 |
Why?
|
| Double-Blind Method | 8 | 2023 | 2588 | 0.290 |
Why?
|
| Prednisone | 2 | 2020 | 984 | 0.270 |
Why?
|
| Gastrointestinal Diseases | 2 | 2009 | 589 | 0.260 |
Why?
|
| Dystrophin | 1 | 2021 | 41 | 0.200 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 116 | 0.190 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2021 | 69 | 0.190 |
Why?
|
| Pain | 1 | 2009 | 1658 | 0.190 |
Why?
|
| Muscle Contraction | 1 | 2021 | 218 | 0.190 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2021 | 142 | 0.190 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 2045 | 0.190 |
Why?
|
| Muscle, Skeletal | 3 | 2021 | 1270 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2021 | 3251 | 0.170 |
Why?
|
| Plasmids | 1 | 2021 | 837 | 0.170 |
Why?
|
| Middle Aged | 13 | 2021 | 86204 | 0.150 |
Why?
|
| Humans | 21 | 2023 | 261506 | 0.150 |
Why?
|
| Mutation | 3 | 2014 | 15179 | 0.150 |
Why?
|
| Adult | 11 | 2023 | 77950 | 0.140 |
Why?
|
| Male | 15 | 2023 | 123000 | 0.140 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2017 | 69 | 0.140 |
Why?
|
| Placebos | 2 | 2021 | 437 | 0.140 |
Why?
|
| Polyneuropathies | 1 | 2015 | 28 | 0.140 |
Why?
|
| Spiro Compounds | 1 | 2015 | 58 | 0.130 |
Why?
|
| Communication | 1 | 2022 | 876 | 0.130 |
Why?
|
| Female | 17 | 2023 | 141928 | 0.130 |
Why?
|
| Treatment Outcome | 8 | 2021 | 32848 | 0.120 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 1375 | 0.120 |
Why?
|
| Action Potentials | 1 | 2017 | 560 | 0.120 |
Why?
|
| Heart Rate | 1 | 2017 | 737 | 0.110 |
Why?
|
| Pain Measurement | 3 | 2021 | 953 | 0.110 |
Why?
|
| Psychometrics | 1 | 2018 | 937 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2021 | 1616 | 0.110 |
Why?
|
| Family Health | 1 | 2014 | 325 | 0.110 |
Why?
|
| Aged | 9 | 2021 | 70117 | 0.110 |
Why?
|
| Pyrazines | 1 | 2015 | 495 | 0.110 |
Why?
|
| Electrocardiography | 2 | 2017 | 1145 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 2016 | 629 | 0.110 |
Why?
|
| Catheter Ablation | 1 | 2017 | 620 | 0.100 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2012 | 151 | 0.100 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2012 | 105 | 0.100 |
Why?
|
| Muscle Weakness | 1 | 2012 | 116 | 0.100 |
Why?
|
| Muscular Atrophy | 1 | 2012 | 105 | 0.100 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 182 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 4320 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2012 | 621 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 5687 | 0.090 |
Why?
|
| Cataract | 1 | 2012 | 218 | 0.090 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2009 | 18 | 0.090 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2009 | 22 | 0.090 |
Why?
|
| Basal Ganglia | 1 | 2009 | 64 | 0.090 |
Why?
|
| RNA, Transfer | 1 | 2009 | 77 | 0.090 |
Why?
|
| Neurologic Examination | 1 | 2009 | 245 | 0.080 |
Why?
|
| Quality of Life | 3 | 2018 | 4532 | 0.080 |
Why?
|
| Ovary | 1 | 2012 | 668 | 0.080 |
Why?
|
| Single-Blind Method | 2 | 2020 | 409 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 980 | 0.070 |
Why?
|
| Analgesics | 1 | 2007 | 390 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 3203 | 0.060 |
Why?
|
| Animals | 4 | 2023 | 59536 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 1648 | 0.050 |
Why?
|
| Isometric Contraction | 1 | 2021 | 18 | 0.050 |
Why?
|
| Biopsy | 1 | 2009 | 3443 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 29902 | 0.050 |
Why?
|
| Walk Test | 1 | 2021 | 43 | 0.050 |
Why?
|
| Time | 1 | 2021 | 178 | 0.050 |
Why?
|
| Injections, Intramuscular | 1 | 2021 | 255 | 0.050 |
Why?
|
| Muscle Strength | 1 | 2021 | 104 | 0.050 |
Why?
|
| Accidental Falls | 1 | 2021 | 142 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2017 | 11965 | 0.040 |
Why?
|
| Disease Progression | 2 | 2023 | 6682 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2020 | 242 | 0.040 |
Why?
|
| Canada | 1 | 2018 | 429 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 2803 | 0.040 |
Why?
|
| Thymoma | 1 | 2020 | 246 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 8865 | 0.040 |
Why?
|
| Young Adult | 4 | 2020 | 21445 | 0.030 |
Why?
|
| Brain | 1 | 2009 | 4113 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 2020 | 400 | 0.030 |
Why?
|
| Time Factors | 1 | 2009 | 12926 | 0.030 |
Why?
|
| United States | 2 | 2023 | 15433 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 4143 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 7702 | 0.030 |
Why?
|
| DNA Polymerase gamma | 1 | 2012 | 15 | 0.030 |
Why?
|
| Glutarates | 1 | 2012 | 44 | 0.030 |
Why?
|
| Ovarian Diseases | 1 | 2012 | 54 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 6086 | 0.020 |
Why?
|
| Age of Onset | 1 | 2012 | 827 | 0.020 |
Why?
|
| Succinate Dehydrogenase | 1 | 2009 | 43 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2009 | 135 | 0.020 |
Why?
|
| Carnitine | 1 | 2009 | 94 | 0.020 |
Why?
|
| Triazines | 1 | 2009 | 117 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 7222 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 31252 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 6009 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 2083 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2012 | 1732 | 0.020 |
Why?
|
| Headache | 1 | 2007 | 163 | 0.020 |
Why?
|
| Drug Eruptions | 1 | 2007 | 256 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 34495 | 0.010 |
Why?
|
| Heart | 1 | 2007 | 1223 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 37905 | 0.010 |
Why?
|